The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
220 jobs Number of planned job losses
Announcement Date
20 September 2011
Employment effect (start)
Foreseen end date
Description
Pharmaceutical manufacturer Pfizer has announced the intention to present a labour force adjustment plan which will entail 220 job cuts across various sites in Spain. The measure is attributed to the increase of health care costs as well as the recently approved decree enforcing a reduction of prices of medicines. The restructuring is expected to affect the company's administrative structure and its retail network in Spain.
Sources
20 September 2011: Expansión
Citation
Eurofound (2011), Pfizer, Internal restructuring in Spain, factsheet number 72394, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/72394.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
